On the other hand, the E2DHT post-treatment in eSCPCOS revealed several DEGs related to androgen action (CDADC1, FOXO1, PDGFRL), supporting the previous findings that estrogen promotes androgen action in the non-PCOS and PCOS endometrium18–20. This evidence concerns the gene CDADC1 and polycystic ovary syndrome.